| Drug Name: | Fludarabine (21679-14-1) |
|---|---|
| PubChem ID: | 657237 |
| SMILES: | C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(N=C2N)F |
| InchiKey: | HBUBKKRHXORPQB-FJFJXFQQSA-N |
| Therapeutic Category: | Antineoplastic Agents |
| Molecular Weight (dalton) | : | 285.235 |
| LogP | : | -1.8409 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 9 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 139.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Pentostatin (53910-25-1) | Pulmonary Toxicity | Synergistic | Unknown | Fludarabine A Review of its Use in Non-Hodgkin’s Lymphom |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category